Total Payments
$1,101
2024 Payments
$560.05
Companies
13
Transactions
27
Medicare Patients
6,509
Medicare Billing
$613,646
Payment Breakdown by Category
Food & Beverage$653.81 (59.4%)
Travel$320.60 (29.1%)
Education$126.32 (11.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $653.81 | 18 | 59.4% |
| Travel and Lodging | $320.60 | 1 | 29.1% |
| Education | $126.32 | 8 | 11.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teleflex LLC | $439.90 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $195.77 | 4 | $0 (2021) |
| Myriad Genetic Laboratories, Inc. | $185.12 | 3 | $0 (2024) |
| Augmenix, Inc. | $74.36 | 1 | $0 (2018) |
| Laborie Medical Technologies Corp. | $59.44 | 3 | $0 (2023) |
| ABBVIE INC. | $36.94 | 2 | $0 (2024) |
| Boston Scientific Corporation | $29.98 | 1 | $0 (2022) |
| PFIZER INC. | $22.60 | 2 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $20.72 | 1 | $0 (2017) |
| UROVANT SCIENCES INC | $17.26 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $560.05 | 6 | Teleflex LLC ($439.90) |
| 2023 | $150.19 | 4 | Myriad Genetic Laboratories, Inc. ($90.75) |
| 2022 | $60.39 | 4 | Boston Scientific Corporation ($29.98) |
| 2021 | $89.99 | 1 | Astellas Pharma US Inc ($89.99) |
| 2020 | $11.10 | 1 | PFIZER INC. ($11.10) |
| 2019 | $105.94 | 6 | Astellas Pharma US Inc ($90.26) |
| 2018 | $91.19 | 3 | Augmenix, Inc. ($74.36) |
| 2017 | $31.88 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($20.72) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Teleflex LLC | UROLIFT (Device) | Travel and Lodging | In-kind items and services | $320.60 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/13/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/12/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $97.90 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 11/07/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $80.63 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/02/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $90.75 | General |
| Category: ONCOLOGY | ||||||
| 09/21/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $22.56 | General |
| 06/21/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $12.87 | General |
| 05/20/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| 07/18/2022 | Boston Scientific Corporation | rezum Generator (Device) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: rezum_URO | ||||||
| 05/12/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $9.33 | General |
| 04/12/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Urology | ||||||
| 02/14/2022 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 01/15/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 02/04/2020 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 11/06/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $78.43 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $11.50 | General |
| Category: ONCOLOGY | ||||||
| 03/04/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $2.33 | General |
| Category: Kidney Stones | ||||||
| 03/04/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.31 | General |
| Category: Kidney Stones | ||||||
| 03/04/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $0.54 | General |
| Category: Kidney Stones | ||||||
| 02/20/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $15.52 | General |
| Category: ONCOLOGY | ||||||
| 09/21/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.31 | General |
| Category: Kidney Stones | ||||||
| 01/24/2018 | Augmenix, Inc. | SpaceOAR (Device) | Food and Beverage | In-kind items and services | $74.36 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,477 | 1,956 | $602,783 | $151,567 |
| 2022 | 26 | 1,422 | 1,854 | $607,506 | $171,562 |
| 2021 | 23 | 1,751 | 3,928 | $469,172 | $136,504 |
| 2020 | 27 | 1,859 | 4,699 | $470,954 | $154,014 |
Total Patients
6,509
Total Services
12,437
Medicare Billing
$613,646
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 144 | 183 | $127,917 | $34,148 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 195 | 241 | $88,688 | $22,223 | 25.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 124 | $63,860 | $16,762 | 26.2% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 18 | 18 | $37,476 | $10,199 | 27.2% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 29 | 30 | $37,365 | $9,990 | 26.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 55 | 55 | $38,445 | $8,727 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 121 | 135 | $35,100 | $8,261 | 23.5% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 16 | 17 | $27,846 | $7,525 | 27.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 57 | 57 | $33,345 | $6,242 | 18.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 42 | 49 | $22,712 | $4,576 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $18,202 | $4,461 | 24.5% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 14 | 41 | $10,414 | $2,737 | 26.3% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 53 | 53 | $8,957 | $2,476 | 27.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 27 | 57 | $8,151 | $2,212 | 27.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 51 | 54 | $8,802 | $2,180 | 24.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 19 | 46 | $8,188 | $1,860 | 22.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $7,087 | $1,834 | 25.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $5,491 | $1,291 | 23.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 47 | $4,606 | $1,283 | 27.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 114 | 144 | $4,464 | $1,148 | 25.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 315 | 488 | $3,904 | $1,060 | 27.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 43 | $1,763 | $372.66 | 21.1% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2022 | 14 | 14 | $113,232 | $35,101 | 31.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 136 | 172 | $114,380 | $33,284 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 227 | $77,407 | $21,634 | 27.9% |
About Dr. David Hutton, MD
Dr. David Hutton, MD is a Urology healthcare provider based in Walla Walla, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932113347.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hutton, MD has received a total of $1,101 in payments from pharmaceutical and medical device companies, with $560.05 received in 2024. These payments were reported across 27 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($653.81).
As a Medicare-enrolled provider, Hutton has provided services to 6,509 Medicare beneficiaries, totaling 12,437 services with total Medicare billing of $613,646. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Walla Walla, WA
- Active Since 07/28/2006
- Last Updated 06/01/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1932113347
Products in Payments
- UROLIFT (Device) $439.90
- PROLARIS (Device) $185.12
- XTANDI (Drug) $117.28
- SpaceOAR (Device) $74.36
- rezum Generator (Device) $29.98
- LUPRON DEPOT (Drug) $25.78
- Xofigo (Drug) $20.72
- GEMTESA (Drug) $17.26
- Lupron (Drug) $11.16
- TOVIAZ (Drug) $11.10
- (815) Thiola (Drug) $5.49
- Thiola (Drug) $3.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.